Publications

Journal papers

Check our latest publications.

"The immune suppressive microenvironment affects efficacy of radio‐immunotherapy in brain metastasis"

K. Niesel Et al., EMBO Mol Med 2021 e13412. LINK.

"Proteomic Analysis of Low-Grade, Early-Stage Endometrial Carcinoma Reveals New Dysregulated Pathways Associated with Cell Death and Cell Signaling"

A. Lopez-Janeiro Et al., Cancers 2021, 13(4), 794. LINK.

"Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections"

D. Migliozzi Et al., Microsystems & Nanoengineering volume 5, Article number 59, 2019 . LINK.

"Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study"

F. Aimi Et al., Virchows Arch. 2019 Jul 2. LINK.

"Microfluidic-based immunohistochemistry combined with next-generation sequencing on diagnostic tissue sections for detection of tumoral BRAF V600E mutation"

A.-L. Leblond Et al., American Journal of Clinical Pathology, 2019. LINK.

"Ultra-fast and automated immunohistofluorescent multistaining using a microfluidic tissue processor"

G. Cappi Et al., Scientific Reports volume 9, Article number 4489, 2019. LINK.

"A microfluidic platform towards automated multiplexed in situ sequencing"

N. Maïno Et al., Scientific Reports volume 9, Article number 3542, 2019. LINK.

“Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma”

S. Brajkovic Et al., Diagnostic Pathology 2018 13:79, October 2018. LINK.

“Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections”

S. Brajkovic Et al., Laboratory Investigation 97, pages 983–991, May 2017. LINK.

"Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer"

H.T. Nguyen Et al., Laboratory Investigation 97, 93-103, January 2017. LINK.

“Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer”

D.G. Dupouy Et al., Scientific Reports no. 6, pp. 20277, 2016. LINK.

"Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs"

A.T. Ciftlik Et al., Proceedings of the National Academy of Sciences USA (PNAS), volume 110, no. 14, pp. 5363-5368, 2013. LINK.